The Yolk Sac (YS) and Aorta-Gonad-Mesonephros (AGM) are two major haematopoietic regions during embryonic development. Interestingly, AGM is the only one generating haematopoietic stem cells (HSCs). To identify the difference between AGM and YS, we compared them using singlecell RNA sequencing between 9.5 and 11.5 days of mouse embryonic development and identified cell populations using CONCLUS, a new computational tool. The AGM was the only one containing neurons and a specific mesenchymal population, while the YS major component was an epithelial population expressing liver marker genes. In addition, the YS contained a major endothelial population expressing Stab2, a hyaluronan receptor, also highly expressed by liver endothelium. We demonstrated that the YS haematopoietic potential was restricted to Stab2negative cells and that ectopic expression of Stab2 could reduce blood cell formation from endothelium. Our results indicate that the AGM is a tissue more favourable to HSCs development than the YS because of its microenvironment and the nature of its endothelial cells.
Introduction
Haematopoietic Stem and Progenitor Cells (HSPCs) emerge from rare haemogenic endothelial cells (HECs) during embryonic development through the process called endothelial-tohaematopoietic transition (EHT) [1] [2] [3] [4] [5] [6] . This transition is known to occur in both large arterial vessels, most notably the Aorta-Gonad-Mesonephros (AGM) and the Yolk Sac (YS), at mid-gestation.
Despite both tissues undergoing EHT to give rise to the burgeoning haematopoietic system, distinct differences have been noted in their contribution to embryonic haematopoiesis.
The AGM region of the mouse embryo has been identified as a key source of haematopoietic stem cells (HSCs) between embryonic (E) days 9.5 and 11.5 7 . These HSCs emerging from the AGM go on to colonise the foetal liver at E12 8 , where they proliferate before seeding the foetal spleen and bone marrow (BM) between E15.5 and E17.5 9 . From here, they will maintain blood cell production throughout the life of the organism.
In contrast to the AGM, the YS is an extra-embryonic membrane surrounding the embryo giving rise to many haematopoietic progenitor cells (HPCs) which lack the self-renewal characteristics of HSCs 7 . One key function of the YS is the production of primitive erythroid cells to support the needs of the growing embryo from E7.25 [10] [11] [12] . Additionally, it contributes to life-long haematopoiesis through the production of multi-potent Erythroid-Myeloid Progenitors (EMPs) from E8.25 [10] [11] [12] , which give rise to definitive cell types including tissue-resident macrophages that persist into adulthood 13, 14 .
Although several studies suggested that HSCs may be produced from the YS [15] [16] [17] [18] , engraftment experiments in avian models and transplantation studies in mice indicated an intraembryonic origin of HSCs [19] [20] [21] [22] To date no explanation has been found to account for the difference in output of EHT that occurs in the YS versus AGM. It is not known whether there are intrinsic differences between the HEC of the two tissues or whether cell-extrinsic factors produced in the microenvironment drive HSC output in the AGM. While the AGM has been studied intensely both at the cellular and molecular levels, comparatively little is known about EHT in the YS due to challenges associated with imaging this tissue and its lack of HSC potential. By comparing the process of EHT between these distinct tissues it could be possible to better understand what is essential to HSC production in the embryo.
A lack of markers identifying HEC has hampered efforts to understand EHT, however, single cell transcriptome analysis has enabled us to make advances towards understanding this rare cell type. Recent work has characterised haemogenic endothelial cells (HECs) of the AGM at the molecular level 23 whereas, the identity of endothelial cells with haemogenic capacity in YS is still unresolved. As such it is interesting to compare the similarities and differences of the haemogenic endothelial cells themselves and the microenvironment of these embryonic haematopoietic tissues.
The microenvironment of the AGM has been more intensely studied than that of the YS. AGM mesenchymal cells and neuronal cells surrounding the aorta have been shown to induce EHT via the production of molecules such as catecholamines 24 , BMP4 [25] [26] [27] and Hedgehog 27 . Much less is known about signalling pathways between endothelial and microenvironment cells in the YS.
Given the precise timing and rare populations involved in EHT, single-cell RNA sequencing (sc-RNA-seq) is an ideal approach to identify and characterise the populations involved in the formation of the haematopoietic system. Recent single-cell atlases covered a broad spectrum of mouse embryonic development between E6.5 and E13.5 28, 29 . However, none of them addressed the differences of EHT between YS and AGM.
Here, we used sc-RNA-seq to investigate one specific key aspect of development, EHT from YS and AGM at E9.5 and E11.5. Analysis of sc-RNA-seq datasets requires sensitive methods for characterising both large clusters of dominant cell types and small populations in a tissue.
Computational methods have been developed to perform clustering on sc-RNA-seq data 30 .
However, these algorithms were not entirely appropriate for our data. Consequently, we designed a CONCLUS allowed us to successful identify and annotate the distinct cell populations in the AGM and YS. Using this method, we identified clear differences between the YS and AGM in the types of cells that make up the microenvironment. Furthermore, although we identified key groups of endothelial cells with clear similarities between the two tissues, we also found a distinct difference in the presence of a dominant Stab2+ population in the YS. Moreover, expression of Stab2 is negatively correlated with haematopoietic potential and could play a role in the differential haematopoietic output observed in the AGM and YS.
Results

Single-cell RNA sequencing analysis of AGM and YS tissues
In an effort to better understand the previously described differences between YS and AGM haematopoiesis, we performed single-cell RNA sequencing at E9.5 and E11.5 (before and after HSC emergence in the AGM). Since endothelial cells represent a small population in these tissues, we enriched for cells expressing the endothelial marker VE-Cadherin (VE-Cad, also called Cdh5) and sorted VE-Cad Negative cells constituting the microenvironment (Fig. 1a ). We then isolated single cells using the SMARTer ICELL8 Single-Cell System 31 . We captured 1,284 cells at E9.5 and 1,482 at E11.5 and sc-RNA-seq was performed. For each run of sequencing, YS and AGM populations from the same time point were combined ( Fig. 1b ) to minimize any potential batch effect. After sequencing, the cell barcodes were used to assign each cell to its corresponding original condition according to the sorting strategy: AGM VE-Cad+, YS VE-Cad+, AGM VE-Cad-, and YS VE-Cad-.
We used several available bioinformatics tools 32-35 but they did not provide a robust clustering solution. For example, when using Seurat 36 , a widely used sc-RNA-seq analysis tool, we noticed that the number of first principal components (PCs) and resolution could change the clustering. Therefore, numerous iterations were needed to identify stable clusters. The Hemberg lab proposed an approach overcoming this issue using an enumerative system of parameters enabling the definition of consensus clusters: SC3 32 . It simplifies the level of knowledge required for handling parameters. However, SC3 was not designed to explore rare populations, unlike GiniClust 37 and RaceID 38 . Moreover, it is highly complex and not suitable for datasets with several thousand cells 39 . Consequently, we reasoned that a tool taking advantage of the SC3 consensus idea, capable of processing thousands of cells and detecting rare populations could enable us to gain new insights into AGM and YS cellular composition.
We devised CONCLUS, an R package providing unsupervised clustering solutions to distinguish large clusters from rare populations accurately. By combining the consensus approach with the DBSCAN algorithm 40 Figure 1a & 1b) . We found seven clusters at E9.5 and eleven at E11.5 ( Fig. 2a ). We could identify marker genes (Supplementary 
AGM and YS tissues have different microenvironments
The most striking difference between AGM and YS was at the level of non-endothelial cell populations. In AGM at E9.5 and E11.5, they were mostly mesenchymal (Mes) cells and neurons.
In YS, at E9.5 non-endothelial cells were mostly primitive erythroid cells and at E11.5 they were a mix of primitive erythroid, mesenchymal and YS-liver like cells ( Fig. 2a ). The presence of mesenchymal cells and neuronal cells in the AGM has already been reported 6,24 so we focused mostly on the clusters of YS microenvironment.
At E11.5 we found the mesenchymal populations of the AGM and YS (AGM_Mes and YS_Mes, respectively) to vary significantly with 1,154 differentially expressed genes (FDR < 0.05).
At E11.5, AGM top 5 mesenchyme markers were Ptn, Mdk Gpc6, Cyr61 and Crabp1 while the YS top 5 were Col1a1, Col1a2, Col3a1, Lum and Acta2 ( Fig. 2b and Supplementary File 2). GO term analysis performed with DAVID Bioinformatics Functional Annotation tool 41, 42 showed that genes overexpressed by AGM_Mes were related to "nervous system development" (FDR= 2.36E-14), "axon guidance" (FDR= 4.75E-09) and "heart development" (FDR= 6.58E-06). In contrast, genes overexpressed by YS_Mes belonged to "collagen fibril organisation" (FDR= 8.41E-10), "endodermal cell differentiation" (FDR= 1.85E-04) and "angiogenesis" (FDR= 4.88E-04) (Supplementary File 1).
Only the AGM contained neuronal cells (AGM_Neurons). We detected them both at E9.5 and E11.5. Following GO term analysis of AGM Neuronal cell marker genes, we found the terms At E11.5 we identified in the YS a small population whose top 5 marker genes were A2m, Smlr1, F2, Pdzk1 and Cubn ( Fig. 2c and Supplementary File 2). Interestingly, these five genes have been reported to be specific to the liver. To know whether these five genes were the only liver markers, we examined the top 150 marker genes of this population. We used the mouse organogenesis cell atlas covering development between E9.5 and E13.5 to investigate the specificity of these genes 28 . This atlas offers the possibility to check the relative quantity of a given transcript across all the cell types detected in this developmental window. Out of these 150 genes, 85 (56.6%) were ranked as the most expressed in foetal hepatocytes, and 21 were listed in second place in terms of expression in hepatocytes in the mouse embryo ( Fig. 2d ). Top GO terms for this population were "cholesterol metabolic process" (FDR= 2.0E-13), "steroid metabolic process" (FDR= 4.5E-12) and "lipid metabolic process" (FDR= 1.85E-10) consistent with the key functions of the liver ( Supplementary File 3) . Overall, 70% of the top 150 genes of this YS population were highly expressed in foetal hepatocytes suggesting a high degree of transcriptional similarity of this YS population to hepatocytes. For this reason, we called it YS_Liver_like. We next decided to examine by microscopy how they were localised compared to the blood vessels. To visualise the YS_Liver_like population, we chose an antibody recognising one of its markers Cdh1 coding for the protein E-Cadherin (E-Cadh) that is expressed by epithelial cells 43 . We stained YS derived from miR144/451 +/GFP mouse embryos. MiR144 and miR451 are micro RNAs specific of red blood cells, both primitive and definitive 44, 45 . GFP marked erythroid cells and allowed us to visualise easily blood vessels in the YS. To our surprise, E-Cadh-positive cells were very abundant in the YS and they surrounded the blood vessels from all sides ( Fig. 2e ) suggesting that they could have a significant influence on the vascular network.
Similar myeloid populations were detected in AGM and YS
Among the identified clusters, we found five with haematopoietic features across the two time points. At E9.5, we detected erythroid cells only in the YS and then in both tissues at E11.5 ( Fig. 2a , Supplementary Files 1 & 2). EMP appeared first in the YS at E9.5 while at E11.5 EMP and mature macrophages were present in both AGM and YS. Of note, these two myeloid cell groups were a composite of cells from the two tissues highlighting their similarity despite their different location ( Fig. 2a , Supplementary Files 1 50 . Interestingly, CD206+ macrophages expressing these genes were recently described to be important in the AGM to help the formation of HSCs 51 .
AGM and YS tissues have different endothelial cell populations
Blood cells come from the vasculature through the EHT process. Consequently, we examined next the endothelial cell populations residing in the AGM and YS tissues. Our study allowed us for the first time to compare endothelial cells from the AGM and YS at E9.5 and E11.5.
Although they had genes in common such as Cdh5, Kdr and Tek, there were large differences in gene expression. At E9.5 there were three endothelial clusters: AGM_EC, AGM_EC_2 and YS_EC ( Fig. 2a ). Between YS_EC and AGM_EC, we found 1,213 differentially expressed genes (FDR < 0.05). Most of them (80.5 %) had a higher expression in the YS_EC group compared to AGM_EC and GO term analysis showed they belonged to the terms "GO:0030036~actin cytoskeleton organization" (FDR= 2.39E-07), "GO:0001525~angiogenesis" (FDR= 4.45E-07) and
"GO:0006897~endocytosis" (FDR= 4.31E-06) (Supplementary File 3).
The comparison of AGM_EC and YS_EC to the AGM_EC_2 group yielded similar lists of differentially expressed genes. The AGM_EC_2 expressed significantly more genes linked to the following GO terms: "GO:0006351~transcription, DNA-templated", "GO:0006355~regulation of transcription, DNA-templated" and "GO:0045944~positive regulation of transcription from RNA polymerase II promoter" suggesting that transcription is more active in these cells compared to the AGM_EC and YS_EC clusters ( Supplementary File 3) .
At E11.5 we identified only one EC cluster per tissue ( Fig. 2a ), and the number of differentially expressed genes went down to 380 (FDR < 0.05). Sixty-nine per cent of these genes were upregulated in YS_EC compared to AGM_EC and part of them belonged to the GO term "GO:0006898~receptor-mediated endocytosis" (FDR= 1.13E-04) similarly to the comparison between YS_EC and AGM_EC at E9.5.
Interestingly, the YS endothelium consistently expressed more the Stab2 and Lyve1 genes at both developmental time points compared to the AGM endothelial cells ( Fig. 3a , Supplementary Files 1 & 2). Stab2 and Lyve1 are two genes coding for receptors involved in hyaluronan endocytosis 52, 53 . They are markers of foetal and adult liver endothelial cells 54 ( Supplementary Fig.   2 ) and help the liver clear hyaluronic acid molecules from the extracellular space 55 . Using flow cytometry, we showed that at E9.5, E10 and E11, Stab2 was expressed by the majority of endothelial cells in the YS while the AGM VE-Cad+ cells were almost all Stab2 negative (Fig. 3b ).
These experiments confirmed our sc-RNA-seq analysis. In addition, microscopy analysis of Stab2 protein expression demonstrated that it was indeed present on YS blood vessels ( Fig. 3c ).
A fraction of YS endothelial cells co-expresses CD44 and Stab2
In a previous study, we demonstrated that in the AGM the haematopoietic capacity was restricted to VE-Cad Pos cells expressing CD44, another hyaluronic acid receptor 23 . The Cd44 gene expression was low in our sc-RNA-seq dataset but it could be a limitation of the 3' end sequencing technology that is less sensitive than full-length transcriptome analysis approaches. Consequently, we tested the expression of CD44 protein by flow cytometry (Fig. 4a ). We found that some endothelial cells in the YS expressed this molecule. As in the AGM, we were able to distinguish three levels of expression among the VE- .4a ). Using confocal microscopy, we confirmed the co-expression of Stab2 and CD44 proteins in the yolk sac vasculature ( Fig. 4b -4c ). Following this finding, we decided to assess the haematopoietic properties of these CD44 Pos YS endothelial cells.
Haematopoietic potential is enriched in the YS CD44 Pos Stab2 Neg endothelial fraction
In the AGM, we defined the haemogenic endothelial cells (HECs) as VE-Cad Pos CD44 Low Kit Neg . These cells were characterised by the expression of Grp126 (Adgrg6), Pde3a, Sox6, Smad6 found five clusters corresponding to two endothelial groups (YS_SC1 and YS_SC2), two coexpressing endothelial and blood genes (YS_SC3 and YS_SC4) and one expressing mostly haematopoietic genes (YS_SC5) ( Fig. 5a ).
To determine the nature of these populations, we compared them computationally to 386 VE-Cad Pos cells from AGM 23 . YS_SC1 cells were closer to the AGM_EC than any other populations while the YS_SC2 were clustering with AGM_HEC. The YS_SC3 group was mixing with the AGM_ProHSPC whereas the YS_SC4 cluster was clustering with AGM_PreHSPC_I.
Finally, the YS_SC5 cells were the most similar to AGM_PreHSPC_II (Fig. 5b) .
In summary, we found that most of the cells expressing Stab2 (Kit Neg and Kit Pos ) or lacking the expression of CD44 displayed a clear endothelial transcriptional signature (Fig. 5c ). In contrast, cells with HEC, Pro-HSPC, Pre-HSPC_I and Pre-HSPC-II transcriptional characteristics were confined to the VE-Cad Pos CD44 Pos Stab2 Neg populations (Fig. 5c ).
This transcriptome analysis suggested that the Stab2 Neg VE-Cad Pos CD44 Low Kit Pos cells would more readily generate blood cells than the Stab2 Pos VE-Cad Pos CD44 Low Kit Pos cells. To test this hypothesis, we sorted 100 cells from each subset on OP9 stromal cells to perform a co-culture supporting the formation of blood cells. Three days following the initial culture on OP9, the wells containing haematopoietic growth were counted. Over seven independent experiments (43 wells in total), 90% of wells which received Stab2 Neg VE-Cad Pos CD44 Low Kit Pos cells gave rise to blood cells versus 8% of wells with Stab2 Pos VE-Cad Pos CD44 Low Kit Pos cells. These results supported the transcriptome analysis and showed that the highest haematopoietic potential was within the Stab2 Neg VE-Cad Pos CD44 Low Kit Pos population ( Fig. 6 ).
Overexpression of Stab2 disrupts EHT in vitro
The fact that the most of the haematopoietic activity in the yolk sac was detected within the Stab2 Neg CD44 Pos compartment prompted us to ask whether or not Stab2 expression could be a hindrance to the formation of blood cells. Previously, we have shown that disrupting the association between CD44 and Hyaluronan could interfere with the formation of blood cells 23 
. A total Stab2
knock-out mouse model does not have any severe phenotype in relation to blood development suggesting that its presence is not essential for blood cell formation 53, 56 . However, its expression on the surface of endothelial cells expressing CD44 might be a brake to blood cell generation.
To assess this possibility, we used the model of in vitro EHT based on the differentiation of embryonic stem cells (ESCs). In this model, a majority of endothelial cells produced by the haemangioblast express CD44 like in the AGM and also co-express Smad6 and Smad7 genes 23 but we did not know whether these cells were expressing Stab2 as well. Using flow cytometry, we tested the expression of this cell surface protein and we were surprised to find that ESC-derived ECs were Stab2 Neg ( Supplementary Fig. 5a ) unlike YS, where Stab2 Pos cells were the dominant endothelial population ( Fig. 3) . Considering that the ESC-derived ECs were Stab2 negative, they provided an excellent opportunity to test the effect of Stab2 overexpression on EHT.
To induce Stab2 expression, we generated an inducible Stab2 (iStab2) ESC line where a transgene coding for a dead Cas9 fused to VP64-p65-RTA (dCAS9-VPR) transcriptional activators was under the control of the Tetracycline Response Element (TRE) promoter while a Stab2 specific guide RNA (gRNA) was expressed under a constitutively active promoter ( Supplementary Fig. 5b ).
An ESC control cell line containing only dCAS9-VPR was also made. Following ESC differentiation into mesoderm, hemangioblast cells were sorted based on Flk1 expression and put in culture. We treated cells with doxycycline (dox) for three days and assessed the expression of VE-Cad and CD41 by flow cytometry. We verified that expression of dCAS9-VPR was induced following dox treatment in both lines ( Supplementary Fig. 5c ). As expected VE-Cad+ cells from the control line did not express Stab2 (Fig. 7a ). In contrast, we could clearly detect a statistically significant increase of Stab2 expression with the iStab2 line even in the no dox condition suggesting that a low level of dCAS9-VPR expression was enough to trigger an upregulation of Stab2 expression ( Fig. 7a ). Addition of dox did not change significantly Stab2 expression. Of note, overexpression of Stab2 was mostly confined to VE-Cad+ cells (CD41+ and CD41-) ( Fig. 7a ).
When we compared the frequency of haematopoietic progenitors (CD41 Pos VE-Cad Neg ) between the control and iStab2 lines in absence of dox, we noted a lower frequency of CD41 Pos VE-Cad Neg cells in the iStab2 culture ( Supplementary Fig. 5d ). We obtained a similar result when we compared iStab2 no dox with iStab2 dox (Fig 7b -7c ). We also noticed an increase of the frequency of endothelial cells following dox treatment (Fig.7c ). These results suggest that expression of Stab2 on endothelial cells could indeed slow down the EHT process.
Discussion
In this study, we performed the first comparison of AGM and Yolk Sac cell composition between E9.5 and E11.5 of mouse embryonic development, the time window in which the definitive hematopoiesis is initiated. While both tissues are sites of embryonic haematopoiesis and undergo EHT, they contribute to the blood system in different ways. It remains unclear what are the similarities and differences between the endothelial cells of the vasculature and their surroundings that results in the differing output at these two sites. Using sc-RNA-seq, we compared the microenvironment and endothelium of each tissue to shed light on the process of EHT.
To analyse the resulting sc-RNA-seq datasets, we developed a consensus-clustering pipeline, CONCLUS, which allowed us to separate the different sub-populations in AGM and YS in more robust way compared to other well-known analysis methods.
Based on our sc-RNA-seq analysis, we found the YS and AGM to contain distinct populations within their microenvironments. The AGM is the only tissue containing neurons and a unique mesenchymal population, which have been involved in HSC generation 24 25-27 . In contrast, the YS is the only tissue containing a cell population of extra-embryonic endodermal origin expressing many marker genes characteristics of foetal hepatocytes. In our sc-RNA-seq data, this population was very small but following immunofluorescence analysis, we found that it was a large. In addition, there is a defect in the yolk sac vascular remodelling emphasizing the cross-talk between epithelial and endothelial cells 57 . Indeed, after comparing the endothelium from AGM and YS, we identified significant differences in gene expression. Strikingly, the YS not only contains a liver-like epithelial population, but the majority of its vasculature expresses liver endothelial marker genes such as Stab2, Lyve1 and Mrc1 that are mostly absent from the AGM endothelium.
Following these results, we focused on the hyaluronan receptor Stab2, the most specific YS endothelial marker. We examined its expression in conjunction with CD44, another hyaluronan receptor. We have shown previously that there was a positive correlation between CD44 expression and haematopoietic identity of cells undergoing EHT in the AGM 23 . Since we knew that coexpression of VE-Cad, CD44 and Kit was an excellent predictor of hematopoietic identity in the AGM, we aimed to find out if the same was true for YS. We found that a substantial fraction of Our sc-RT-PCR results suggest similarities between AGM and YS regarding the populations involved in EHT. It is surprising considering the very different microenvironments that these tissues display. The expression of CD44 without Stab2 is specific of arterial endothelium, as we have shown previously 23 . Since the YS also contains arterial endothelial cells belonging to the vitelline artery 61 , this would explain our observations. It also suggests that the haematopoietic signature we observed in both AGM and YS CD44 Pos Stab2 Neg cells can arise independently of the microenvironment where the EHT takes place. However, the appropriate microenvironment is essential for the acquisition of HSC properties following EHT. Only the AGM has the proper cellular context for this process of maturation to occur.
Stab2 and CD44 are both hyaluronic acid (HA) receptors but they might antagonize each other if they are expressed together on the same cells due to their different modes of action. The role of HA in enhancing haematopoiesis was reported in multiple studies 23, 62, 63 . We found that the interaction between CD44 and HA was beneficial to the EHT in the AGM and in the ESC based model of in vitro EHT. In contrast, Stab2 performs systemic clearance of HA from the extracellular matrix 64 , which could reduce the interaction of CD44 with its ligand. The ectopic expression of Stab2 in our in vitro EHT model led to a significant reduction of haematopoietic output similarly to the disruption of CD44 binding to HA 23 . Since the induction of Stab2 by dCAS9-VPR was restricted to VE-Cad+ cells, possibly because the Stab2 locus was more accessible in these cells compared to the other cell types in our culture, it suggests that the effect of Stab2 on EHT is affecting endothelial cells directly.
In conclusion, our work provides an important resource to understand the difference of haematopoietic outputs between AGM and YS. Moreover, it will pave the way to better define what is needed for endothelial cells to become blood cells. Finally, it further supports the importance of HA receptors at the onset of haematopoietic development. This knowledge will help further the development of cell culture methods to produce HSCs for therapeutic purposes.
Materials and Methods
Mouse lines and Embryo dissection generation
C57BL/6 and miR144/451 GFP/GFP two to three month-old mice were used for timed mating. Embryos were obtained by timed mating between C57BL/6 wild-type mice or between miR144/451 GFP/GFP and C57BL/6 mice. Pregnant mice were killed by cervical dislocation between E9.5 and E11.5 of gestation. Uterine horns were collected; the maternal tissues were removed as well as the placenta to isolate the embryos. Embryos were collected in PBS supplemented with 10% FBS (PAA Laboratories). The yolk sac was torn gently and separated from the embryo proper by tearing off the umbilical and vitelline arteries. Then, the somite pairs of the embryos were counted to determine their developmental stage (E9.5-E11.5). To isolate the AGM, the head, tail, limb buds, ventral organs and somites were removed. Yolk sac and AGM samples from the same embryonic development stage were pooled together in the same tube. To generate single-cell suspension from the isolated tissues, AGM and yolk sac samples were digested with collagenase (Sigma C9722) for 30 minutes at 37°C, then stained as described below and taken to flow cytometry sorting.
Flow cytometry sorting of AGM and YS for single-cell RNA sequencing experiments
Single cell suspensions of wild type AGM and YS at E9.5 and E11.5 were stained with rat anti-mouse CD144-efluor660 1:200 (eBioscience #50-1441-82, clone eBIOBV13) and 7AAD (Sigma, #A9400). Cells were analyzed and sorted on FACSAria (BD). After gating on cells and doublet exclusion, live 7AAD-cells were bulk sorted into 15ml falcons as VE-Cad Pos endothelial cells and VE-Cad Neg microenvironment cells, and taken for dispensing on ICELL8 chip (Takara), as described below.
We performed one experiment with E9. 5 
Single-cell RNA sequencing data pre-processing
Quality control of reads was done using the fastqc software. Then we separated reads by cell barcodes and saved them into one file per cell. Adapters were removed using cutadapt and alignment to the mouse genome mm10 (GRCm38.86) was done using STAR. We counted reads that overlapped exactly with one gene. Then for calculating Unique Molecular Identifiers (UMIs), we took into account the possibility of mutations in the UMI barcode caused by inaccurate sequencing. We assumed that two UMI barcodes with a difference of two mismatches could originate from one. If there was such a pair where one of UMI barcodes had only 10% of reads from another one, we joined those reads considering it as one UMI. In this way, we reduced the amount of false-positive UMIs. We created a UMI count matrix where columns were cells; rows were gene features. We did not include in a count matrix UMIs that had less than two reads. Later, we considered a gene to be expressed if it had at least one UMI.
Single-cell RNA sequencing downstream analysis with CONCLUS
To perform cells quality check, we looked at the distribution across all cells of such features as the number of genes (i) per cell, the percentage of UMIs related to protein-coding genes (ii), the total number of UMIs (iii), and percentage of UMIs related to mitochondrial genes (iv). The first three metrics were considered 'positive', the last one -'negative'. For example, the more genes were detected in a cell, the better. On the opposite, an abnormally high percentage of mitochondrial counts in comparison to all other cells could mean that a cell was damaged and leaking. For each feature, we calculated the first (Q1) and the third (Q3) quartiles and the interquartile range (IQR).
For the positive characteristics, we removed all cells with values below Q1-1.5*IQR and for the negative one above Q3+1. After cells filtering, we selected only genes with more than ten total counts and created a SingleCellExperiment object containing a count matrix with UMIs and metadata. We computed factors with Scran 65 and used them for normalising the data 66 . For calculating the factors, we used the following values for parameters: sizes = c(20, 40, 60, 80, 100) and clusters from a quickCluster function of Scran. Usually, if a cell has a factor equal or less than zero, it must be removed. But in our case, all factors were positive, so the number of cells did not change after normalisation. We deleted highly abundant haemoglobins having names starting with 'Hba' or 'Hbb' because they seemed to be the primary source of contamination in both datasets. Additionally, we excluded poorly annotated genes that did not have gene symbols to improve the clusters annotation process.
It resulted in 11836 genes at E9.5 and 11434 at E11.5 that we used for clustering analysis and marker selection.
For calculating coordinates of two-dimensional t-SNE, we used the following ranges of clustering iterations were two cells were in one cluster. Consensus grouping was performed using a cutree function on the dendrogram of the similarity matrix. We explicitly asked the function to split the E9.5 dataset into eight groups and E11.5 set into 13. Two groups in E9.5 YS VE-Cad+ were merged into YS_EC because the difference between them was explained by a slight gradient of gene expression. E9.5 YS_EC is indeed a group where cells have different transcriptional biases, however, not yet clear marker genes. At E11.5, we assigned a tiny, noisy group of cells to the closest cluster AGM_Ery, and additionally merged two almost equal sized groups into YS_Ery because they were similar to E9.5, that separation was supported only by the weak gradient of gene expression but not significant positive markers. Eventually, we obtained 7 clusters at E9.5 and 11 groups at E11.5 with distinct positive marker genes that were used for annotation.
To calculate the probability that a gene was a positive marker, we performed t-test with hypothesis "greater" for all possible pairs between a cluster of interest and all other groups. Note that the variance of a gene was estimated by taking all cells in the dataset, not only two compared clusters. For further ranking, we used FDR from these comparisons and information on how close two groups were to each other. We assumed that it is more probable to find a DE gene between two very distinct groups than between two similar groups. Thus we slightly raised the ranking of genes that allowed separating similar groups. The information about the distance between clusters we obtained from a similarity matrix of clusters. Similarity matrix of clusters is a simplified "bulk" version of the similarity matrix of cells where we calculated the median value for each group.
For a cluster k and a gene G, a score G was defined in the following way:
• fdr k,i is an adjusted p-value obtained by comparing expression of the gene G in cluster k versus expression of G in cluster i;
• weight k,i is a similarity between two groups. We defined it as the <k,i> element of the clusters similarity matrix plus 0.05 (to avoid zero scores in case if a group has zero similarity with others);
• nClusters is a number of consensus clusters;
• =10 −300 is a small number which does not influence the ranking and added to avoid an error when fdr is equal to zero;
• k = [1,...,nClusters];
• i = ( [1,.. 
.,nClusters] except for [k])
A gene with the highest score was assigned as the best positive marker for a cluster. To sum up, CONsensus CLUStering workflow (CONCLUS) (Fig. 1c, 1d , Sup. Fig. 3 ) includes such steps as cells and genes filtering, normalisation, similarity matrices of cells and clusters, consensus clustering, visualisation, and marker selection. The last step in CONCLUS is collecting information about marker genes from publicly available databases NCBI (citation), UniProt 67 , and MGI 68 (Fig.   1c ).
Analysis of the Mouse organogenesis Atlas and Tabula Muris dataset
Seurat v.2 was used to perform sc-RNA-seq clustering analysis on the data retrieved from the Mouse Organogenesis Cell Atlas 28 . We took the filtered data "cds_cleaned.RDS" from which the doublet and low-mRNA cells were removed. For annotation and metadata the "cell_annotation.csv" table was used.
We selected the cells related to the "Endothelial trajectory". For these files we created
Seurat object and ran clustering analysis including normalization with "LogNormalize" method.
Afterwards, we found 4890 variable genes using the following parameters: x.low.cutoff = 0.0125,
x.high.cutoff = 3, y.cutoff = 0.5. Next, we performed a scaling with linear model regressed on the number of UMI and clustering with dimensions 1:20 and resolution 1.0. With clustered data we generated t-SNE plots highlighting the genes we were interested in (Supplementary Figure 3) . The expression matrix was then processed through the CONCLUS pipeline with similar parameters to our AGM and YS datasets. We then generated t-SNE plots highlighting the expression pattern of Cdh5, Stab2 and Lyve1 genes ( Supplementary Figure 3) .
The Tabula Muris Gene-count table for FACS sorted adult Liver cells was downloaded from
Single-cell q-RT-PCR analysis.
This experiment was performed exactly as described previously 69 using the Fluidigm Biomark system. Data analysis was also done as before 69 .
Yolk Sac flow cytometry sorting and clonogenic OP9 assays.
Yolk sacs from E10-E10.5 embryos were dissected and dissociated as described above, then filtered through a 50μm sterile filcon (BD Biosciences #340630) to obtain a single cell suspension.
The cells were counted and stained with the following rat anti-mouse antibodies: VE-Cad/CD144- 
Immunofluorescence and confocal microscopy
The E11.5 Yolk sacs from miR144/451 +/GFP mouse embryos were first collected in 1xPBS+10% Fetal Bovine Serum (10270106, Gibco). Upon dissection they were fixed in 4%
Paraformaldehyde solution in PBS (sc-281692, Santa Cruz) for 1hour at room temperature. After they were washed 3 times for 10min with 1x PBS, then incubated for 15min in 1xPBS with 20mM
Glycine (G8898, SigmaAldrich). They were permeabilised for 30min in 1xPBS with 0. Mixtures were heated at 95 o C for 3 min and then incubated at room temperature for 30 min.
Generation of ESC lines and in vitro ESC differentiation into blood and vascular lineages
A ligation reaction with sgRNA and linearised pPB_mU6_BFP was performed for 1h at room temperature using the reaction mix (annealed sgRNA 0.8 μ l, vector 3.9 μ l, buffer 2 μ l, T4 ligase 1 μ l, water 12.3 μ l). Ligated sgRNA and plasmids were transformed into DH10B bacteria.
After overnight incubation at 37 o C, colonies were picked, miniprep was prepared using 5
NucleoSpin Plasmid/Plasmid (NoLid) protocol. Then a PCR reaction was performed using the forward primer (CTGCCCCGGTTAATTTGCAT) within the plasmid and the oligo 2 to detect if the ligation worked. For positive clones, an overnight midi-prep (50ml) with 1ml of culture was set up and DNA was purified using NucleoBond Xtra Midi/Maxi (Machery-Nigel, #740410.50).
To generate the iStab2 ESC line, A2loxEmpty ES cells 69 Twenty-four hours after the transfection, cells were treated with 200μg/ml HygromycinB (CalBiochem, #400051) in the morning and evening for two days and then only in the morning for 5 more days. After 7 days of antibiotic treatment, cells were FACS Aria sorted for BFP on 96-well plate of mouse embryonic fibroblasts. Fastest growing clones were selected and split until they were confluent for one well of a 6-well plate.
ES cells were then subjected to in vitro differentiation into Embryoid bodies to produce blood, endothelial and vascular smooth muscle cells following the same protocol described previously 69 .
Data availability
The raw count matrices and corresponding metadata for our sc-RNA-seq datasets can be 
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